| 4/20/2006 | BTCV | S&P boosts Chiron
|
| 11/4/2005 | CV | Market Commentary: Qwest, Chesapeake remain active; Celgene up, Emdeon lower; King sideways
|
| 11/1/2005 | BTCV | Moody's puts Chiron on positive review
|
| 10/31/2005 | BTCV | S&P keeps Chiron on positive watch
|
| 10/31/2005 | CV | Market Commentary: Merger news spurs trades in Placer Dome, Chiron, Leucadia and Level 3
|
| 10/21/2005 | CV | Market Commentary: Wyeth holds up; Ford drops, but GM bonds move higher; Schlumberger off
|
| 10/20/2005 | CV | Market Commentary: Convertibles market reverses course after strong start; Cypress pulled down; Amgen, biotechs weaker
|
| 10/19/2005 | BTCV | S&P ups Chiron watch to positive
|
| 10/11/2005 | CV | Market Commentary: GM, Ford trade mixed, but remain market focus; Skyworks holds up after lower guidance; Inco rises
|
| 9/21/2005 | CV | Market Commentary: Chesapeake, Devon/Chevron trade; Chiron down; Nektar launches deal; Citi/Genworth prices
|
| 9/6/2005 | CV | Market Commentary: Chiron trades mixed, but Curagen gains; Dobson Communications to price $150 million issue
|
| 9/2/2005 | BTCV | Moody's affirms Chiron, view developing
|
| 9/2/2005 | CV | Market Commentary: Albertson's mandatories lag as stock surges; Northwest Airlines, Delta weaken further
|
| 9/1/2005 | CV | Market Commentary: Airtran, Northwest lead airline convertibles lower; autos sink; Chiron, Phar Pharma gain
|
| 7/15/2005 | CV | Market Commentary: Chiron drops as convertibles market trades mostly flat to lower; but CV Therapeutics, Isis gain
|
| 6/15/2005 | CV | Market Commentary: Convertibles catch wave of optimism as new Invitrogen deal gains favor; Saks sinks after default notice
|
| 4/11/2005 | CV | Market Commentary: El Paso at bat with sweeter terms; Nabi emerges; Ford plummets in wake of warning; Impax steadies
|
| 3/7/2005 | CV | Market Commentary: Genworth synthetic coming; Cell Therapeutics dives; Celgene rises; Saks bagged up; Lions Gate higher
|
| 3/2/2005 | CV | Market Commentary: Chiron boosted by lifting of U.K. flu vaccine ban; Charter slips further; Maurel & Prom trades up
|
| 3/2/2005 | CV | S&P: Chiron still on watch
|
| 1/12/2005 | CV | New Issue: ABN Amro sells $450,000 10.5% reverse exchangeables linked to Chiron
|
| 12/20/2004 | CV | Moody's downgrades Chiron
|
| 12/13/2004 | CV | Chiron changes some payments on 1 5/8% convertibles to cash only
|
| 11/23/2004 | CV | New Issue: Goldman prices $3.5 million notes exchangeable for Chiron at 2%, up 35%
|
| 11/19/2004 | CV | New Issue: Goldman prices $10.72 million notes exchangeable for Chiron
|
| 10/12/2004 | CV | Market Commentary: Apex Silver hovers around par; Amkor firms as bids hit; NPS Pharma, biotechs suffer
|
| 10/6/2004 | CV | Moody's may cut Chiron
|
| 10/6/2004 | CV | Market Commentary: Boston Private advances deal; Chiron spreads widen, AMD tighter; Sirius firms on Stern deal
|
| 10/5/2004 | CV | S&P: Chiron on watch
|
| 10/5/2004 | CV | Market Commentary: General Mills issue rises; Chiron, Henry Schein fall on flu scare but MedImmune gains
|
| 10/5/2004 | CV | Market Commentary: General Mills issue rises; Chiron, Henry Schein fall on flu scare but MedImmune gains
|
| 8/31/2004 | CV | Market Commentary: Six Flags higher on Gates, Redskins owner play; IMC Global rises; Albertson's off
|
| 8/30/2004 | CV | Market Commentary: LNR convertible leveled by $1.9 billion cash takeover; United Rentals falls on SEC inquiry
|
| 6/23/2004 | CV | S&P rates Chiron convertibles
|
| 6/23/2004 | CV | Market Commentary: Calpine powered up by arbs; Matria gains; Nextel Partners soars; two new deals emerge
|
| 6/17/2004 | CV | New Issue: Chiron $350 million convertible yields 2.75%, up 49.4%
|
| 6/17/2004 | CV | Market Commentary: Chiron goes to 101, Advanced Medical to 103.5; Kellwood to 101.5; Delta reverses, heads up
|
| 6/16/2004 | CV | Market Commentary: Advanced Medical prices with wide coupon; Kellwood seen offered at 100.5; Delta plunges; JetBlue warns
|
| 6/16/2004 | CV | Chiron $350 million overnight convertible talked at 2.25%-2.75%, up 48%-52%
|
| 6/15/2004 | CV | Chiron says $649.9 million of LYONs put back
|
| 5/14/2004 | CV | Chiron to pay upcoming put on LYONs in cash
|
| 12/16/2003 | CV | Market Commentary: Four deals to price after the close Tuesday; Mentor adds $125 million overnighter
|
| 7/25/2003 | CV | New Issue: Chiron $450 million overnight convertibles yield 1.625%, up 47.5%
|
| 7/25/2003 | CV | Market Commentary: Quantum downsizes, sweetens deal as late surge of deals find many players on summer break
|
| 7/24/2003 | CV | Chiron $450 million overnight convertible talked at 1.5-1.75%, up 45-50%
|
| 7/24/2003 | CV | S&P rates new Chiron convert A-
|
| 7/24/2003 | CV | Market Commentary: Health Management breakfast deal reoffered at 98.75 to whet buyers' palate; four deals pricing after close
|
| 12/12/2001 | CV | Chiron 0% convertibles offer cheap volatility, Deutsche analysts say
|
| 11/21/2001 | CV | Market Commentary: Convertible market dips slightly, ready for break to digest new issues
|
